Years of research and thousands of surgical hours have helped turn hip replacement surgery into one of the most common medical interventions performed, with great clinical outcomes. As populations age, we can only expect this highly successful procedure to grow.

A new class of hip implants, Optimised Equivalent®, is designed to help healthcare providers manage increasing demand and provide the best outcome for patients. Developed from the most reliable, tried and tested hip replacement technology, Optimised Equivalents® are less expensive than the reference branded implants and are now made available within a totally transparent and flexible pricing structure. This development is similar to the well accepted emergence of generics in pharmaceuticals.

Each component of the Optimised Equivalent® total hip implants has been meticulously evaluated from over one million hip replacement operations to identify the stem, head and cup with the lowest revision rates.

At a time of unprecedented cost pressures on Healthcare systems worldwide, the Optimised Equivalent® implants make a valuable contribution towards maintaining high quality hip replacement services within the limited resources available.